Bio-Techne (TECH) News Today $64.92 -0.57 (-0.87%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$64.96 +0.03 (+0.05%) As of 02/21/2025 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Bio-Techne Corp (TECH) Expands RNAscope Probes Portfolio to Enhance Spatial Biology ResearchFebruary 21 at 1:14 PM | gurufocus.comBio-Techne (NASDAQ:TECH) Rating Lowered to "Hold" at Baird R WBaird R W cut shares of Bio-Techne from a "strong-buy" rating to a "hold" rating in a research report on Wednesday.February 21 at 8:22 AM | marketbeat.comOwnership Capital B.V. Sells 67,835 Shares of Bio-Techne Co. (NASDAQ:TECH)Ownership Capital B.V. decreased its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 7.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 906,813 shares of the biotechnology company's stock after selling 67,835 shares during the periFebruary 21 at 5:50 AM | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Position Increased by New York State Common Retirement FundNew York State Common Retirement Fund increased its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 4.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 544,058 sharesFebruary 21 at 4:19 AM | marketbeat.comVontobel Holding Ltd. Cuts Position in Bio-Techne Co. (NASDAQ:TECH)Vontobel Holding Ltd. reduced its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 46.0% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 5,229 shares of the biotechnology company's stock after selling 4,462 shares during the period. VontobeFebruary 21 at 3:23 AM | marketbeat.comBio-Techne (NASDAQ:TECH) Downgraded by Baird R W to "Hold"February 21 at 1:52 AM | americanbankingnews.comBio-Techne expanded menu of RNAscope probesFebruary 20 at 8:48 AM | markets.businessinsider.comBio-Techne (NASDAQ:TECH) Lowered to Neutral Rating by Robert W. BairdRobert W. Baird downgraded shares of Bio-Techne from an "outperform" rating to a "neutral" rating and lowered their price objective for the stock from $88.00 to $68.00 in a research note on Wednesday.February 20 at 7:24 AM | marketbeat.comBio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial BiologyFebruary 20 at 7:00 AM | prnewswire.comBio-Techne (NASDAQ:TECH) Stock Rating Lowered by Robert W. BairdFebruary 20 at 2:53 AM | americanbankingnews.comBaird Downgrades Bio-Techne (TECH)February 19 at 7:36 PM | msn.comBio-Techne Co. (NASDAQ:TECH) Director Sells $122,685.60 in StockBio-Techne Co. (NASDAQ:TECH - Get Free Report) Director Amy E. Herr sold 1,860 shares of the business's stock in a transaction on Friday, February 14th. The shares were sold at an average price of $65.96, for a total transaction of $122,685.60. Following the sale, the director now directly owns 1,976 shares of the company's stock, valued at $130,336.96. This represents a 48.49 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.February 19 at 5:15 PM | marketbeat.comDeep Dive Into Bio-Techne Stock: Analyst Perspectives (4 Ratings)February 19 at 7:41 AM | benzinga.comBio-Techne downgraded to Neutral from Outperform at BairdFebruary 19 at 7:41 AM | markets.businessinsider.comBio-Techne Corp (TECH) Unveils GMP TcBuster Non-Viral Genome Engineering SystemFebruary 19 at 6:24 AM | gurufocus.comBio-Techne Stock Outlook: Is Wall Street Bullish or Bearish?February 19 at 2:41 AM | msn.comBio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering SystemFebruary 18, 2025 | prnewswire.comPembroke Management LTD Trims Holdings in Bio-Techne Co. (NASDAQ:TECH)Pembroke Management LTD reduced its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 17.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 260,042 shares of the biotechnology company'sFebruary 18, 2025 | marketbeat.comKornitzer Capital Management Inc. KS Has $13.11 Million Holdings in Bio-Techne Co. (NASDAQ:TECH)Kornitzer Capital Management Inc. KS trimmed its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 22.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 181,934 shares of the biotechnology comFebruary 18, 2025 | marketbeat.comVan ECK Associates Corp Increases Stock Holdings in Bio-Techne Co. (NASDAQ:TECH)Van ECK Associates Corp grew its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 40.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 171,557 shares of the biotechnology company's stock after acquiring an addFebruary 16, 2025 | marketbeat.comEarnings call transcript: Bio-Techne Q4 2024 beats EPS forecastFebruary 14, 2025 | msn.comAllspring Global Investments Holdings LLC Has $52.64 Million Stake in Bio-Techne Co. (NASDAQ:TECH)Allspring Global Investments Holdings LLC lifted its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 12.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 736,340 shares of the biotechnologyFebruary 14, 2025 | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Receives Consensus Rating of "Moderate Buy" from AnalystsBio-Techne Co. (NASDAQ:TECH - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the seven research firms that are currently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and five have issued a bFebruary 13, 2025 | marketbeat.com4,474 Shares in Bio-Techne Co. (NASDAQ:TECH) Bought by Summit Trail Advisors LLCSummit Trail Advisors LLC purchased a new stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 4,474 shares of the biotechnology company's stock, valued at approximately $322,000.February 13, 2025 | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Position Reduced by State of Alaska Department of RevenueState of Alaska Department of Revenue reduced its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 44.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 18,119 shares of theFebruary 13, 2025 | marketbeat.comMirae Asset Global Investments Co. Ltd. Grows Stake in Bio-Techne Co. (NASDAQ:TECH)Mirae Asset Global Investments Co. Ltd. raised its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 46.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 16,650 shares of the biotechnology company's stock after purchasing an additional 5,295 shaFebruary 12, 2025 | marketbeat.comQ4 EPS Estimates for Bio-Techne Decreased by Leerink PartnrsFebruary 12, 2025 | americanbankingnews.comWilliam Blair Has Negative Outlook of Bio-Techne Q4 EarningsFebruary 12, 2025 | americanbankingnews.comBio-Techne Corp. stock underperforms Monday when compared to competitorsFebruary 11, 2025 | msn.comBio-Techne (NASDAQ:TECH) Shares Gap Down - Time to Sell?Bio-Techne (NASDAQ:TECH) Shares Gap Down - Here's What HappenedFebruary 10, 2025 | marketbeat.comLab equipment stocks drop as NIH cuts loomFebruary 10, 2025 | msn.comLeerink Partnrs Reduces Earnings Estimates for Bio-TechneBio-Techne Co. (NASDAQ:TECH - Free Report) - Investment analysts at Leerink Partnrs dropped their Q4 2025 EPS estimates for shares of Bio-Techne in a report released on Wednesday, February 5th. Leerink Partnrs analyst P. Souda now forecasts that the biotechnology company will post earnings of $0.February 10, 2025 | marketbeat.comWilliam Blair Analysts Cut Earnings Estimates for Bio-TechneBio-Techne Co. (NASDAQ:TECH - Free Report) - Research analysts at William Blair cut their Q4 2025 earnings estimates for Bio-Techne in a research report issued to clients and investors on Wednesday, February 5th. William Blair analyst M. Larew now anticipates that the biotechnology company will eFebruary 10, 2025 | marketbeat.comStephens Investment Management Group LLC Acquires 60,109 Shares of Bio-Techne Co. (NASDAQ:TECH)Stephens Investment Management Group LLC raised its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 8.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 734,675 shares of the biotechnologyFebruary 9, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Raises Holdings in Bio-Techne Co. (NASDAQ:TECH)Sumitomo Mitsui Trust Group Inc. boosted its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 21.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,040,840 shares of the biotechnologyFebruary 8, 2025 | marketbeat.comBeyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH)February 8, 2025 | gurufocus.comQ2 2025 Bio-Techne Corp Earnings CallFebruary 6, 2025 | finance.yahoo.comBio-Techne price target raised to $90 from $80 at KeyBancFebruary 6, 2025 | markets.businessinsider.comBio-Techne price target raised to $90 from $88 at ScotiabankFebruary 6, 2025 | markets.businessinsider.comBio-Techne (NASDAQ:TECH) Given New $80.00 Price Target at Royal Bank of CanadaRoyal Bank of Canada boosted their price target on Bio-Techne from $79.00 to $80.00 and gave the stock a "sector perform" rating in a research report on Thursday.February 6, 2025 | marketbeat.comBio-Techne (NASDAQ:TECH) Stock Price Expected to Rise, Scotiabank Analyst SaysScotiabank upped their price target on Bio-Techne from $88.00 to $90.00 and gave the stock a "sector outperform" rating in a research note on Thursday.February 6, 2025 | marketbeat.comKeyCorp Raises Bio-Techne (NASDAQ:TECH) Price Target to $90.00KeyCorp upped their target price on Bio-Techne from $80.00 to $90.00 and gave the company an "overweight" rating in a research report on Thursday.February 6, 2025 | marketbeat.comBio-Techne Corp (TECH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...February 6, 2025 | gurufocus.comQ2 2025 Bio-Techne Corp Earnings Call TranscriptFebruary 6, 2025 | gurufocus.comBio-Techne reports Q2 adjusted EPS 42c, consensus 38cFebruary 5, 2025 | markets.businessinsider.comBio-Techne beats Q2 earnings estimates on improving demand for biotech productsFebruary 5, 2025 | reuters.comBio-Techne signals high single-digit growth recovery by Q4 2025, driven by biopharma momentumFebruary 5, 2025 | msn.comBio-Techne (NASDAQ:TECH) Surprises With Strong Q4, Stock SoarsFebruary 5, 2025 | finance.yahoo.comBio-Techne Corporation (TECH) Q2 2025 Earnings Call TranscriptFebruary 5, 2025 | seekingalpha.comBio-Techne (NASDAQ:TECH) Releases Earnings Results, Misses Estimates By $0.03 EPSBio-Techne (NASDAQ:TECH - Get Free Report) released its quarterly earnings data on Wednesday. The biotechnology company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.38 by ($0.03). Bio-Techne had a net margin of 12.86% and a return on equity of 12.76%.February 5, 2025 | marketbeat.com Get Bio-Techne News Delivered to You Automatically Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter. Email Address TECH Media Mentions By Week TECH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TECH News Sentiment▼0.320.60▲Average Medical News Sentiment TECH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TECH Articles This Week▼238▲TECH Articles Average Week Get Bio-Techne News Delivered to You Automatically Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies A News Today MTD News Today WAT News Today ILMN News Today CRL News Today BIO News Today BRKR News Today PACB News Today HBIO News Today TMO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TECH) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Techne Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Techne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TECH Stock Alerts